Header

UZH-Logo

Maintenance Infos

Hépatite C: traitement actuel


Moradpour, Darius; Müllhaupt, Beat (2015). Hépatite C: traitement actuel. Revue Médicale Suisse, 11(471):902-906.

Abstract

Treatment of chronic hepatitis C is currently being revolutionised, with the introduction of directly acting antivirals (DAA), including protease, NS5A and polymerase inhibitors. These can be combined in interferon-free oral therapies with unprecedented efficacy and good tolerance. Here, we review the current therapy of chronic hepatitis C, with a particular focus on DAA that are approved in Switzerland today.

Abstract

Treatment of chronic hepatitis C is currently being revolutionised, with the introduction of directly acting antivirals (DAA), including protease, NS5A and polymerase inhibitors. These can be combined in interferon-free oral therapies with unprecedented efficacy and good tolerance. Here, we review the current therapy of chronic hepatitis C, with a particular focus on DAA that are approved in Switzerland today.

Statistics

Altmetrics

Additional indexing

Other titles:Hepatitis C: current therapy
Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Gastroenterology and Hepatology
Dewey Decimal Classification:610 Medicine & health
Language:French
Date:22 April 2015
Deposited On:05 Jan 2016 10:29
Last Modified:08 Dec 2017 16:31
Publisher:Group M+H -Medecine et Hygiene
ISSN:1660-9379
Free access at:Publisher DOI. An embargo period may apply.
Related URLs:http://www.revmed.ch/mh (Publisher)
PubMed ID:26072595

Download

Full text not available from this repository.